相关实验视频
Updated: Sep 13, 2025

08:35
In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
10.3K
METTL3通过准TFEB来调节自性,用于心肌缩
Yanan Xie1, Wei Jiao1, Hongchao Wang1
1Department of Cardiology, The Second Hospital of Hebei Medical University.
International heart journal
|July 30, 2025
概括
甲基转移酶METTL3通过m6A修饰抑制转录因子TFEB,从而损害了自和恶化了病理性心肌缩. 准m6A-TFEB通路可能为心力衰竭提供新的治疗方法.
科学领域:
- 分子生物学分子生物学
- 心血管研究研究心血管研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 病理性心肌缩 (PMH) 涉及自功能受损和亡的增加.
- 在PMH中N6-甲基氨酸 (m6A) 甲基化及其调节者的作用尚未完全理解.
- 转录因子EB (TFEB) 是自的关键调节者,但其在PMH中的调节需要澄清.
研究的目的:
- 研究PMH中m6A甲基化的机制.
- 确定METTL3是否调节TFEB表达和核转位.
- 阐明METTL3-TFEB相互作用对自活动和PMH发展的影响.
主要方法:
- 在体内 (横向大动脉收缩) 和体内 (Angiotensin II刺激的H9C2细胞) 建立的PMH模型.
- 使用了HE染色,西式涂抹,qRT-PCR,免疫光和自流量分析.
- 进行了m6A MeRIP-qPCR和RIP-qPCR以评估m6A修饰和转录稳定性.
主要成果:
- PMH模型显示自性受损,细胞亡升高,TFEB表达减少和核局部化.
- 全球m6A甲基化增加,METTL3和HNRNPD上调和ALKBH5下调.
- 过度表达METTL3加剧了PMH和自功能障碍;METTL3倒置部分恢复了自功能,通过调节TFEB前mRNA稳定性进行调节.
结论:
- 通过m6A修饰,METTL3抑制TFEB表达,导致自功能障碍和恶化的心肌缩.
- m6A-TFEB轴在PMH的发病过程中起着至关重要的作用.
- m6A-TFEB通路代表了肌心缩和心力衰竭的潜在治疗标.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Autophagic Cell Death
3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K

